Warning letter
Wellcare Rx Investments LLC dba Denson's Specialty Pharmacy: warning letter of Sep 30, 2016
FDA warning letter 506635 · Chicago District Office
Key facts
| Reference number | 506635 |
|---|---|
| Company | Wellcare Rx Investments LLC dba Denson's Specialty Pharmacy |
| Subject | Compounding Pharmacy/Adulteration/Misbranding |
| Issue date | Sep 30, 2016 |
| Posted date | Nov 1, 2016 |
| Issuing office | Chicago District Office |
| Product type | Drugs |
| CFR sections cited | 201.115, 210, 211, 211.28(a), 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.113(b), 211.166(a), 211.167(a) |
| Inspection city | Wheaton |
| Inspection ZIP | 60187 |
| Inspection start date | Aug 12, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: